Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Medigus Ltd ADR

Healthcare US MDGS

NoneUSD
-(-%)

Last update at 2024-07-24T15:01:29.903699Z

Day Range

--
LowHigh

52 Week Range

1.506.91
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap4.47M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.17200M
  • Revenue TTM110.28M
  • Revenue Per Share TTM67.31
  • Gross Profit TTM 4.80M
  • Diluted EPS TTM-8.7

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -10.09700M 4.15M -6.84100M -14.17900M -6.57800M
Minority interest 0.39M 2.75M 3.23M 1.42M 1.42M
Net income -10.20800M 4.05M -6.85000M -14.17800M -6.59800M
Selling general administrative 14.17M 9.96M 5.49M 13.18M 3.34M
Selling and marketing expenses 4.01M 1.99M 0.47M 0.33M 1.35M
Gross profit 14.45M 4.80M -0.50300M -0.18200M -0.17100M
Reconciled depreciation 3.24M 0.32M 0.17M 0.07M 0.04M
Ebit -13.78400M -8.19600M -7.38400M -14.42000M -6.82000M
Ebitda -11.98800M -22.22500M -7.88700M -14.45500M -6.77800M
Depreciation and amortization 1.80M -14.02900M -0.50300M -0.03500M 0.04M
Non operating income net other - - - - -
Operating income -13.78400M -8.19600M -7.38400M -14.42000M -6.67200M
Other operating expenses 100.44M 18.31M 8.00M 14.57M 7.11M
Interest expense -4.08000M 29.44M 3.74M 0.35M 0.00000M
Tax provision 0.11M 0.10M 0.00900M -0.00100M 0.02M
Interest income - - - 0.14M 0.15M
Net interest income -2.30900M -0.34700M 0.20M 0.10M -0.05400M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 0.11M 0.10M 0.00900M -0.00100M 0.02M
Total revenue 91.86M 10.12M 0.53M 0.27M 0.44M
Total operating expenses 23.03M 13.00M 6.96M 14.11M 6.50M
Cost of revenue 77.41M 5.32M 1.03M 0.46M 0.61M
Total other income expense net 3.69M 12.35M 0.54M 0.24M 0.15M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -10.20800M 4.05M -6.85000M -14.17800M -6.59800M
Net income applicable to common shares - 6.79M -4.32500M -14.17800M -6.59800M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 63.90M 97.65M 59.73M 32.34M 13.33M
Intangible assets 18.79M 21.79M 7.39M - -
Earning assets - - - - -
Other current assets 1.11M 0.18M 0.27M 0.38M 0.19M
Total liab 31.46M 42.96M 8.30M 6.14M 5.20M
Total stockholder equity 23.58M 39.14M 49.19M 22.96M 6.71M
Deferred long term liab - - 0.84M - -
Other current liab 3.04M 10.41M 4.90M 3.25M 2.67M
Common stock - - - 93.02M 22.80M
Capital stock 0.00000M 0.00000M 0.00000M 93.02M 22.80M
Retained earnings -101.61000M -85.58600M -74.18800M -80.98200M -76.65700M
Other liab - - 0.97M 2.58M 1.80M
Good will 8.55M 9.07M 0.93M - -
Other assets - - 0.84M 1.15M 4.09M
Cash 9.36M 20.07M 24.02M 22.36M 7.04M
Cash and equivalents - - - - -
Total current liabilities 29.27M 37.63M 6.64M 3.51M 3.37M
Current deferred revenue 3.90M 0.05M 0.11M 0.07M 0.50M
Net debt 0.43M -9.93000M -22.40900M -22.25600M -6.88400M
Short term debt 9.08M 6.74M 0.93M 0.06M 0.12M
Short long term debt 8.98M 6.61M 0.93M - -
Short long term debt total 9.79M 10.13M 1.62M 0.11M 0.15M
Other stockholder equity 113.08M 111.52M 110.76M 0.20M 48.07M
Property plant equipment - - 0.08M 0.37M 0.27M
Total current assets 31.67M 52.26M 31.65M 24.05M 8.28M
Long term investments 3.77M 13.13M 18.84M 6.19M 4.76M
Net tangible assets - - 40.87M 22.39M 6.69M
Short term investments 3.18M 4.99M 3.31M - 0.00000M
Net receivables 15.64M 25.23M 1.69M 0.26M 0.07M
Long term debt 0.23M 2.88M 0.69M - -
Inventory 2.39M 1.79M 1.23M 0.24M 0.90M
Accounts payable 13.25M 20.42M 0.70M 0.14M 0.07M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 12.11M 13.21M 12.62M 10.72M 12.49M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - 0.84M 1.15M 5.05M
Deferred long term asset charges - - - - -
Non current assets total 32.23M 45.39M 28.08M 8.29M 5.05M
Capital lease obligations 0.57M 0.64M 0.00000M 0.11M 0.15M
Long term debt total - - - - 0.03M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -4.47600M -2.82000M -1.81800M -4.11900M 3.49M
Change to liabilities - -0.03600M 0.26M 1.84M 0.17M
Total cashflows from investing activities - -12.44600M -1.60100M -4.11900M 3.49M
Net borrowings - 0.43M -0.04600M -0.04600M -0.04600M
Total cash from financing activities 5.41M 19.15M 22.95M 3.16M 8.63M
Change to operating activities - 1.18M -0.01300M 0.20M 0.12M
Net income -10.09700M 4.15M -6.84100M -14.17900M -6.57800M
Change in cash -3.96000M 1.66M 15.33M -3.58900M 7.80M
Begin period cash flow 24.02M 22.36M 7.04M 10.62M 2.83M
End period cash flow 20.07M 24.02M 22.36M 7.04M 10.62M
Total cash from operating activities -5.65600M -5.25000M -6.14300M -2.69500M -4.22200M
Issuance of capital stock 12.57M 18.72M 22.99M 0.00000M 8.63M
Depreciation 3.24M 0.32M 0.17M 0.07M 0.04M
Other cashflows from investing activities - -1.47000M -1.47000M -4.05700M 3.50M
Dividends paid -4.18600M - -0.12000M - 0.00000M
Change to inventory -0.56400M -0.55100M -0.47300M -0.81900M 0.02M
Change to account receivables -7.83800M -0.23900M -0.07400M 0.00200M -0.00600M
Sale purchase of stock - - -22.94600M - 8.63M
Other cashflows from financing activities 1.75M 1.92M 0.12M 3.20M 3.49M
Change to netincome - -12.48200M -1.68100M 10.19M 2.03M
Capital expenditures 0.07M 0.14M 0.32M 0.06M 0.01M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.11700M 0.12M -0.27600M 1.22M 0.31M
Stock based compensation 0.79M 2.36M 1.39M 0.26M 0.16M
Other non cash items 1.15M 0.58M 0.54M 10.03M -0.04200M
Free cash flow -5.73000M -5.39100M -6.46700M -2.75700M -4.23300M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MDGS
Medigus Ltd ADR		 - -% - - - 0.04 0.15 0.02 -0.1788
ABT
Abbott Laboratories		 -2.1 1.86% 110.55 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -7.27 1.99% 358.65 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -1.45 1.59% 89.89 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -1.94 2.70% 69.96 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Medigus Ltd ADR

10 Hanechoshet, Tel Aviv, Israel, 6971072

Key Executives

Name Title Year Born
Mr. Liron Carmel Chief Exec. Officer 1985
Ms. Tali Dinar Chief Financial Officer 1971
Dr. Yaron Silberman Chief Exec. Officer of ScoutCam Ltd. 1970
Ilan Oren Exec. Officer NA
Mr. Liron Carmel Chief Executive Officer 1985
Dr. Yaron Silberman Chief Executive Officer of ScoutCam Ltd. 1970
Ilan Oren Executive Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.